Navigation Links
First-ever Gamma Knife in Paris Offers New Treatment Options for Patients With Cancer and Other Brain Disorders
Date:5/10/2011

PARIS, May 10, 2011 /PRNewswire/ -- Groupe Hospitalier Pitie Salpetriere, a world-renowned teaching hospital, and among Europe's largest medical centers has continued its long tradition of excellence in neurosciences and its expertise in radiation therapy with the acquisition of Leksell Gamma Knife® Perfexion™. On October 25, 2010, clinicians used Perfexion – Paris's first and only dedicated radiosurgery system – to treat Salpetriere's first patient, a 55-year-old woman with a brain metastasis.

"Her Gamma Knife® surgery went very well and her follow up examination in February showed she is doing well post-operatively," says Charles Ambroise Valery, M.D., a neurosurgeon and head of the radiosurgery department at 1,600-bed Salpetriere. "Perfexion will have a huge impact due to our large population and the incidence of cerebral pathologies that can be treated with radiosurgery. Neurosurgeons have confidence in Gamma Knife, and particularly in Perfexion because it is designed as a dedicated specialist tool for intracranial brain diseases in contrast with other radiosurgery systems. In two or three years, I predict we could treat 700 patients per year."

Gamma Knife surgery is a gentler alternative to traditional brain surgery for illnesses such as metastatic disease – cancer that has traveled to the brain from elsewhere in the body. The system precisely delivers up to thousands of low-intensity radiation beams to one or more targets in a single session. Perfexion provides even greater speed and ease of use than previous models, especially for treating multiple metastases.

Solution for multiple brain metastases

Since October, Salpetriere has treated about 177 patients presenting 375 lesions, of which about 75 percent were patients with brain metastases.

Since 2005, Salpetriere had been using a linac-based system equipped with "micro multi-leaf" beam shaping technology to treat patients with
'/>"/>

SOURCE Elekta
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Patient Receives vProtect(TM) Luminal Shield in First-Ever Vulnerable Plaque Clinical Trial
2. Eularis Releases First-Ever Study on ROI of Pre-Launch Named Patient Programmes
3. Bayer Consumer Care Launches Citracal(R) Calcium Plus Heart Health, First-Ever Leading Calcium Supplement to Help Support Bone AND Heart Health
4. VELOCITY Broadcasting Introduces HD2PC(SM), the First-Ever High-Definition Direct to PC Delivery of Private Broadcast Television
5. CPG Implements First-Ever Agile PLM Release 9.3 at Avema Pharma Solutions
6. FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology
7. Stereotaxis Announces First-Ever, Prospective, Comparative Clinical Trial Outcome for VT Patients
8. Arthritis Foundation and Takeda Launch First-Ever National Gout Public Service Announcement (PSA) Campaign, Urging People Living With Gout to Keep Enjoying Lifes Simple Pleasures
9. FHSSA and the African Palliative Care Association Launch the First-Ever Pain Management Initiative in The Gambia, Kenya, and Malawi
10. Wellsense Unveils First-Ever Bedside Patient Pressure Mapping System Designed to Assist Caregivers in Effectively Repositioning Patients
11. Baxter and The Alzheimers Disease Cooperative Study Group to Pursue a Phase III Study of Gammagard Liquid in Patients With Alzheimers Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX), a clinical-stage ... regeneration, today announced that J.J. Finkelstein , chief ... corporate overview at two upcoming investor conferences. ... th Annual Microcap Conference on Thursday May 28, ... at 11:00 am EDT.  A webcast will be available ...
(Date:5/22/2015)... According to a new market research report ... by Test Type (Indirect, Enzyme-based, Reactive Oxygen Species (ROS)-based), ... - Global Forecast to 2020", published by MarketsandMarkets, the global ... Million by 2020 from $452.36 Million in 2015, growing ... 71 market data Tables and 90 Figures spread through ...
(Date:5/22/2015)... 22, 2015  In a sweeping analysis assessing the ... T1D Exchange researchers conclude that there remains considerable ... across all age groups, but especially for adolescents and ... of diabetes treatment, underscoring the need to address barriers ... can help type 1 patients achieve optimal metabolic control. ...
Breaking Medicine Technology:RegeneRx to Present at 2 Investor Conferences 2RegeneRx to Present at 2 Investor Conferences 3Oxidative Stress Assays Market Worth $736.85 Million by 2020 2Oxidative Stress Assays Market Worth $736.85 Million by 2020 3Oxidative Stress Assays Market Worth $736.85 Million by 2020 4Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 2Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 3Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 4Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 5
... , PRINCETON, N.J. and SAN DIEGO, ... biotechnology company committed to research and product discovery for ... announced results from an in vitro study evaluating TBR-652 ... tenofovir (TDF), etravirine (ETV), and raltegravir (RAL) using the ...
... PARIS and TARRYTOWN, N.Y., Sept. 11 Sanofi-aventis ... Pharmaceuticals, Inc. (Nasdaq: REGN ) today announced the ... Trap) plus gemcitabine versus placebo plus gemcitabine for the first-line ... by an Independent Data Monitoring Committee (IDMC). As part ...
Cached Medicine Technology:Tobira Therapeutics Inc. Announces In Vitro Data of TBR-652 for the Treatment of HIV 2Phase 3 Trial of Aflibercept in Metastatic Pancreatic Cancer Discontinued 2Phase 3 Trial of Aflibercept in Metastatic Pancreatic Cancer Discontinued 3Phase 3 Trial of Aflibercept in Metastatic Pancreatic Cancer Discontinued 4Phase 3 Trial of Aflibercept in Metastatic Pancreatic Cancer Discontinued 5
(Date:5/22/2015)... Family, friends, students, colleagues, mentors and fellow ... LaSalle D. Leffall, on Monday, May 18, with an ... Rounds in the hospital’s Tower Auditorium. Leffall’s younger sister, ... trying to keep the secret. “I’d like to go ... he’ll know something is up,” she said. , After ...
(Date:5/22/2015)... May 22, 2015 According to a new ... generations are equally as likely to worry about what will ... Gen X, 77% Boomers, 69% Silent Generation), which may help ... are scared of aging, particularly Millennials (47%), Gen X’ers (51%), ... Poll in April, 2015 among more than 2,000 U.S. adults ...
(Date:5/22/2015)... Philadelphia, PA (PRWEB) May 22, 2015 According ... as a hub for drug related death, totaling almost 2,500 ... number, as reported by state officials, totals 2,489 deaths stemming ... numbers work out, Pennsylvania loses seven people every day to ... Philadelphia has been singled out as one of the most ...
(Date:5/22/2015)... 2015 sweetFrog Enterprises, LLC. is pleased to ... Jacksonville is now the 16th sweetFrog store located in the ... as #22 on the Inc. 500 list of fastest growing ... worked in East Texas for 20 years and love the ... the Jacksonville, and nearby Palestine, sweetFrog locations. “We are really ...
(Date:5/22/2015)... Ticket Down is a reputable source for ... Eastern Conference Finals Tickets . All seating for the ... the ticket listing. , For the first time in ... of the Eastern Conference. One of the original franchises in ... and downs over the years, but the excitement level for ...
Breaking Medicine News(10 mins):Health News:Colleagues Surprise Dr. LaSalle Leffall with 85th Birthday Celebration 2Health News:New Study Reveals America’s Fear of Aging 2Health News:New Study Reveals America’s Fear of Aging 3Health News:Philadelphia Ranks Among the Tops Cities in Penn. for Drug Deaths 2Health News:sweetFrog Opens New Location in Jacksonville, Texas 2Health News:Cheap Lightning vs Rangers NHL Eastern Conference Finals Tickets: Ticket Down Slashes Ticket Prices on New York Rangers vs Tampa Bay Lightning Eastern Conference Playoffs 2Health News:Cheap Lightning vs Rangers NHL Eastern Conference Finals Tickets: Ticket Down Slashes Ticket Prices on New York Rangers vs Tampa Bay Lightning Eastern Conference Playoffs 3
... with Vital Information Missed by Hemoglobin A1c Test to More ... ... WINSTON-SALEM, N.C., July 17 Toyota Tsusho,America, Inc. (New York, NY) ... a new joint venture company, GlycoMark,Inc., dedicated to the discovery and ...
... A person,s heart rate can reveal a lot about how ... Technology academic says. , Economics Associate Professor Uwe Dulleck, from ... necessarily a bad thing, because it was, in fact, a ... , Professor Dulleck is leading the Australian arm of a ...
... help those at risk of obesity or with high ... babies ready to graduate from breast milk or formula ... they receive whole milk, instead of reduced-fat or fat-free ... of Pediatrics (AAP) now advise parents of toddlers who ...
... WeissComm Partners,the largest privately-held PR firm focused ... among the top five Best Midsize,Agencies to Work ... Report., The Holmes Report, which recently named ... approximately 4,700 PR professionals to assess,overall job satisfaction ...
... Assigns PDUFA Date of January 2, 2009 -, ... DDS;,NASDAQ: DDSS) today announced that the response that it ... July 2, 2008, including the,additional analysis of existing data ... complete, Class 2 response. The action date assigned by ...
... Medicine and Molecular Imaging online community to allow medical imaging professionals ... of medical imaging. , ... London, UK (PRWEB) July ... MGT) announces the launch of a focused Nuclear Medicine and ...
Cached Medicine News:Health News:Toyota Tsusho America, Inc. and Nippon Kayaku Co., Ltd. Announce the Formation of GlycoMark, Inc., a Joint Venture to Develop and Commercialize Novel Biomarkers for Diabetes 2Health News:Toyota Tsusho America, Inc. and Nippon Kayaku Co., Ltd. Announce the Formation of GlycoMark, Inc., a Joint Venture to Develop and Commercialize Novel Biomarkers for Diabetes 3Health News:Decisions under pressure: it's all in the heartbeat 2Health News:Low-Fat Milk OK for Some Toddlers 2Health News:WeissComm Partners Ranks Among Top 5 Best U.S. Midsize PR Agencies to Work For 2Health News:FDA accepts Labopharm's response for once-daily tramadol as complete Class 2 response 2Health News:Medicexchange.com Launches a New Dedicated Nuclear Medicine and Molecular Imaging Community for Medical Imaging Professionals 2
... The Brasseler USA™ Battery Packs contain rechargeable ... have a great impact upon battery life. ... necessary. Any deviation from these recommendations will ... sensitive to heat. Any exposure of the ...
... powered system, offers precision with ease ... procedures. The system can be utilized ... oral, maxillofacial, podiatric and otology techniques. ... a high speed drill, low speed ...
Pneumatic oscillating saw, 35k cpm, available with various hose connector styles....
Pneumatic extended oscillating saw, 35k cpm, available with various hose connector styles....
Medicine Products: